Google Ad

US vaccine reveals sturdy immune response to Covid in scientific trials – Home Health Choices

Washington: The US pharmaceutical and medical system firm Johnson and Johnson has developed a vaccine that within the early trials confirmed a powerful immune response to the novel coronavirus with a single dose, an interim report printed on the medical web site medRxiv revealed.

“The safety profile and immunogenicity after only a single dose are supportive for further clinical development of [vaccine] Ad26.COV2.S at a dose level of 5×1010 vp, as a potentially protective vaccine against COVID-19,” the report mentioned on Friday. “A single dose of Ad26.COV2.S elicited strong humoral responses in the vast majority of vaccine recipients.”

The Johnson and Johnson vaccine is the fourth within the United States to enter the ultimate section of scientific trials.

President Donald Trump has promised that 100 million doses of a vaccine can be distributed all through the United States by the top of the yr. Trump mentioned a vaccine might be accessible for distribution earlier than the presidential election on November three.

Many Democrats have accused Trump of making an attempt to fast-track the vaccine approval course of with the intention to get one delivered forward of the November election.

Follow and join with us on , Facebook, Linkedin

Latest Updates

Related Post